Dysregulation of the interleukin-2 receptor α- and β-chain expression in CD4 and CD8 T cells in HIV infection

Communications in Clinical Cytometry

Volumn 30, Issue 6, 1997, Pages 289-295

  Johnson, N ^a   Parkin, J M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Human immunodeficiency virus; Interleukin 2 receptor; Lymphocyte activation

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; PHENOTYPE; PHYTOHEMAGGLUTININS; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; UP-REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031465709     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19971215)30:6<289::AID-CYTO4>3.0.CO;2-B     Document Type: Article

References (31)

1. Borthwick NJ, Bofill M, Gombert WM, Akbar AN, Medina E, Sagawa K, Lipman MC, Johnson MA, Janossy G: Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28-T cells. AIDS 8:431-441, 1994.
2. Brinchmann JE, Dobluog JH, Heger BH, Haaheim LL, Sannes M, Egelund T: Expression of costimulatory molecule CD28: Functional and clinical correlation. J Infect Dis 169:730-738, 1995.
3. + lymphocytes during HIV infection. Scand J Immunol 40:485-490, 1994.
4. Chilson OP, Kelly-Chilson AE: Mitogenic lectins bind to the antigen receptor on human lymphocytes. Eur J Immunol 19:389-396, 1993.
5. Chopra RK, Raj NBK, Scally JP, Donnenberg AD, Adler WH, Saah AJ, Magolick JB: Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men. Clin Exp Immunol 91:18-24, 1994.
6. Clark AGB, Holodniy M, Schwartz DH, Katzenstein DA, Merigan TC: Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine administration. J AIDS 5:52-59, 1994.
7. Clerici M, Shearer GM: A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107-111, 1994.
8. Clerici, M, Hakin FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic human immunodeficiency virus-seropositive individuals. J Clin Invest 91:759-765, 1992.
9. Emilie D, Peuchmaur M, Crevon MC: Production of interleukins in human immunodeficiency virus 1-replicating lymph nodes. J Clin Invest 86:148-159, 1990.
10. Fan J, Bass HZ, Fahey HL: Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection. J Immunol 151:5031-5040, 1993.
11. Graziosi C, Panteleo G, Gantt KR, Fortin JP, Demarest JF, Cohen OJ, Sekaly RP: Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 265:248-252, 1994.
12. Hofmann B, Nishania P, Fahey JL, Esmail I, Jackson AL, Detels R, Cumberland W: Serum increases and lymphoid losses of IL-2 receptor CD25 in HIV infection: Distinctive parameters of HIV-induced change. Clin Immunol Immunopathol 61:212-224, 1991.
13. Honda M, Kitamura K, Matsuda K: Soluble IL-2 receptors in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterization. J Immunol 142:4248-4255, 1989.
14. kk dissociation. J Immunol 154:2996-3005, 1995.
15. Klimas N, Patarca R, Walling J, Garcia R, Mayer V, Moody D, Okarma T, Fletcher MA: Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interleukin-2 infusion. AIDS 8:1073-1081, 1994.
16. Kovacs JA, Vogel S, Albert JM, Falloon J, Davey RJ Jr., Walker RE, Polis MA, Metcalf JA, Baseler M, Fyfe G, Lane MC: Controlled trial of interleukin-2 infusions in patients with the human immunodeficiency virus. New EnglJ Med 335:1350-1356, 1996.
17. +) T cell activation. Clin Immunol Immunopathol 67:185-191, 1993.
18. + T helper cell depletion occurs. J Clin Invest 82:1908-1914, 1988.
19. Nakamura Y, Russell SM, Mess SA, Friedmann M, Erdos M, Francois C, Jacques Y, Adelstein S, Leonard WJ: Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domain is required for signaling. Nature 369:330-333, 1994.
20. Nye KE, Knox KA, Pinching AJ: Lymphocytes from HIV-infected individuals show aberrant inositol polyphosphate metabolism which reverses after zidovudine therapy. AIDS 5:413-417, 1994.
21. Prince HE, Kleinmann S, Williams AE: Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV. J Immunol 140:1139-1141, 1988.
22. Prince HE, Kleinman SC, Czaplicki JJ, Williams AE: Interrelationships between serological markers of immune activation and T lymphocyte subsets in HIV infection. J AIDS 3:525-530, 1989.
23. Roos MTL, Miedema F, Koot M, Tersmette M, Schaasberg WP: T cell function in vitro is and independent marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J Infect Dis 191:531-536, 1995
24. Scott-Algara D, Vuillier F, Maresescu M, De Saint-Martin J, Dighiero J: Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1 infected patients. AIDS Res Hum Retroviruses 7:381-386, 1991.
25. Sheldon A, Flego L, Zola H: Coexpression of IL-2 receptor p55 and p75 by circulating blood lymphocytes. J Leukocyte Biol 53:161-167, 1993.
26. Volberding P, Dewey DJ, Bearsdlee D, Bradley EC, Wofsy CB: Therapy of acquired immune deficiency syndrome with recombinant interleukin-2. AIDS Res Hum Retroviruses 3:115-124, 1987.
27. Winkelstein A, Kingsley LA, Klein RS, Lyter DW, Evans TL, Rinaldo CR Jr., Weaver LD, Machen LL, Schadle RC: Defective T-cell colony formation and IL-2 receptor expression at all stages of HIV infection. Clin Exp Immunol 71:412-422, 1988.
28. Winkelstein A, Kingsley LA, Waever LD, Machen LL: Defective T cell colony formation and IL-2 receptor expression in HIV-infected homosexuals: Relationship between functional abnormalities and CD4 cell numbers. J AIDS 2:353-358, 1989.
29. Wood R, Montoya JG, Kundu SK, Schartz DS, Merrigan TC: Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: A phase I/II study. J Infect Dis 167:519-525, 1994.
30. Zambello R, Trentin L, Benetti R, et al.: Expression of a functional p75 interleukin-2 receptor on lung lymphocytes from patients with human immunodeficiency virus type 1 (HIV-1) infection. J Clin Immunol 12:37-380, 1993.
31. Zola H, Koh XY, Mantizioris BX, Rhodes D: Patients with HIV infection have a reduced proportion of lymphocytes expressing the IL-2 receptor p55 chain (TAC, CD25). Clin Immunol Immunopathol 59:16-25, 1988.